[Home](/)/[Resources](/resources)/India Medical Device Rule 2017 IndiaCDSCO / MDR # India Medical Device Rule 2017: What Foreign Importers Must Know The Medical Device Rules 2017 transformed India's medical device landscape — from a system covering only 23 notified products to a phased universal regulation covering all medical devices. Every foreign manufacturer now needs an Authorized Agent in India and a CDSCO import license for each regulated device model sold commercially in India. Copy Link[Share on WhatsApp](https://wa.me/?text=https%3A%2F%2Fkrono-labs.com%2Fguides%2Findia-medical-device-rule-2017) At a glance Key provisions 8 Changes from pre-2017 6 Sugam portal steps 6 ## Key provisions of MDR 2017 for importers ### Universal device coverage MDR 2017 brought all medical devices under regulation (not just 23 pre-2017 notified products). New device categories are notified in phases. Check current Schedule I for your device category. ### Risk-based classification (A/B/C/D) Four risk classes determine approval pathway: Class A (low risk) — self-certification; Class B (low-medium) — State Licensing Authority; Class C and D (high risk) — Central Licensing Authority (CDSCO). ### Import license (Form MD-14) All foreign manufacturers importing medical devices must obtain an import license from CDSCO via Sugam portal. License is product-specific — each device model requires its own license. ### Authorized Agent requirement Every foreign manufacturer must appoint a resident Indian Authorized Agent (AA) to apply for and hold the import license. The AA is responsible for all CDSCO regulatory obligations in India. ### Post-market vigilance License holders must report serious adverse events and field safety corrective actions (FSCAs) to CDSCO within defined timelines (typically 10 days for life-threatening events, 30 days for others). ### Quality Management System ISO 13485 QMS certification (or equivalent recognized by CDSCO) is required for manufacturers. The QMS scope must cover the specific device categories for which approval is sought. ### Clinical performance/investigation Class C and D devices may require clinical data from Indian studies or data demonstrated to be applicable to the Indian patient population. CDSCO can require local bridging studies. ### Licence validity and renewal Import licenses are typically valid for 5 years and renewable. CDSCO can suspend or cancel licenses for non-compliance, quality failures, or missing post-market obligations. ## What changed from pre-2017 regulation Pre-2017: only 23 device categories were regulated. Post-2017: all medical devices are regulated in phases under Schedule I notifications. Pre-2017: no risk-based classification. Post-2017: four-class (A/B/C/D) risk-based system aligned with GHTF/IMDRF framework. Pre-2017: no mandatory post-market vigilance requirement. Post-2017: adverse event reporting and FSCAs are mandatory. Pre-2017: no Quality Management System requirement formally specified. Post-2017: ISO 13485 or equivalent is required. Pre-2017: no Authorized Agent concept formally in place. Post-2017: Authorized Agent appointment is mandatory for all foreign manufacturers. Pre-2017: import licensing for some devices only. Post-2017: universal import licensing requirement for all regulated devices. ## Getting your import license: Sugam portal steps 01 ### Register on CDSCO Sugam portal Go to sugam.gov.in. Register as a 'Manufacturer (Overseas)' or through your Authorized Agent. The Authorized Agent typically holds the account and manages all submissions. 02 ### Classify your device and identify applicable schedule Use CDSCO's device classification guidance to confirm device class (A/B/C/D). Confirm your device is listed in Schedule I as notified — if not yet notified, check the current phase-in timeline. 03 ### Prepare the dossier Compile all required documents: Free Sale Certificate, ISO 13485, device description, technical documentation, clinical data, and complete Instructions for Use in English. 04 ### Submit Form MD-14 application The Authorized Agent submits Form MD-14 for import license through Sugam, uploads all documents, and pays the prescribed fee. CDSCO Technical Officer reviews the dossier. 05 ### Respond to CDSCO queries CDSCO may issue deficiency letters or queries on the dossier. Timely responses (typically within 30 days per query notice) are critical to avoid application rejection. 06 ### Receive import license and maintain compliance CDSCO issues Form MD-15 (import license) after approval. Maintain post-market obligations: adverse event reporting, FSCA reporting, and QMS surveillance. ## Frequently asked questions ### What is the difference between an Authorized Agent and an Indian distributor? The Authorized Agent (AA) is the regulatory contact designated under MDR 2017 to apply for and hold the CDSCO import license on behalf of the foreign manufacturer. The AA bears regulatory responsibility. An Indian distributor is a commercial entity responsible for sales and distribution. The same Indian company can be both the AA and the distributor, but the roles and responsibilities are distinct. The AA must be specifically appointed in writing by the manufacturer. ### My device has CE marking — does that simplify CDSCO approval? CE marking (EU MDR or EU IVDR) is a reference point for CDSCO and can support the dossier, but it does not automatically grant or substitute for CDSCO approval. India has its own regulatory pathway. However, CE documentation (technical file, clinical data, Notified Body certificate) substantially overlaps with CDSCO requirements and reduces the work needed to assemble the Indian dossier. CDSCO may still require India-specific labeling and may request additional data. ### Can I import medical devices for evaluation or demo without an import license? Yes — samples for clinical investigation, evaluation, or demonstration can be imported under CDSCO's free sample import permission (Form MD-11/MD-12) without a full import license. These permissions are quantity-limited and time-bound. The device cannot be commercially sold or used for clinical purposes on patients without the full import license. Prior permission from CDSCO is required before the sample import. ### What happens if my device becomes newly notified while I am already selling it in India? When CDSCO notifies a new device category under Schedule I, a transition period is given (typically 18–36 months). During this period, companies already selling the device must apply for and obtain CDSCO registration. Failure to obtain registration by the end of the transition period makes further sales non-compliant. Companies should proactively monitor CDSCO Schedule I notifications for their product categories. **Disclaimer:** This guide reflects the Medical Device Rules 2017 and current CDSCO procedures as of the latest amendments. Schedule I device phase-in timelines and fee structures are subject to change by CDSCO notifications. Always verify current requirements on the CDSCO Sugam portal. 🇮🇳 India roadmap for medical devices Every standard, document, and test that applies — free, no account required. See your free roadmap[ Want an expert to take medical devices through 🇮🇳 India compliance for you? One consultant from Krono's compliance team takes your product from requirements to legal sale, with a fixed quote before any work starts. See compliance services](/services) Learn this properly In-depth course that teaches the full process, not just this one answer. [Start the course — $199](/courses/14-cdsco-medical-device-registration-india)[Prefer to read? Get the book — $24.99](/books/14-cdsco-medical-device-registration-india) Related guides * [CDSCO Medical Device Import LicenseComplete guide to CDSCO medical device import licensing: application process, required documents, Authorized Agent requirements…](/guides/cdsco-import-license) * [CDSCO IVD RegulationComplete guide to CDSCO IVD regulation in India: IVD classification under Medical Device Rules 2017, import license requirement…](/guides/cdsco-ivd-regulation) * [CDSCO Medical Device VigilanceCDSCO adverse event reporting for medical devices: the 15-day rule under MDR 2017, the MvPI MDAE form, FSCA and recall…](/guides/cdsco-vigilance-reporting) * [India Product Safety Recall ProceduresPractical guide to product recall in India: voluntary vs mandatory recall obligations under Consumer Protection Act 2019, BIS A…](/guides/india-product-recall-procedures)